Cargando…
Cetuximab plus FOLFOX for Patients with Metastatic Colorectal Cancer with Poor Performance Status and/or Severe Tumor-Related Complications
INTRODUCTION: Cetuximab-based chemotherapy showed a statistically significantly higher response rate compared with chemotherapy such as FOLFOX. Therefore, FOLFOX plus cetuximab is suspected to be the best regimen to alleviate tumor-related symptoms with a high response rate. CASE REPORT: Here we pre...
Autores principales: | Shitara, Kohei, Yokota, Tomoya, Takahari, Daisuke, Shibata, Takashi, Sato, Yozo, Tajika, Masahiro, Ura, Takashi, Muro, Kei |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3042020/ https://www.ncbi.nlm.nih.gov/pubmed/21347194 http://dx.doi.org/10.1159/000319474 |
Ejemplares similares
-
A Case of Advanced Gastric Cancer with Poor Performance Status Which Improved by Chemotherapy
por: Shitara, Kohei, et al.
Publicado: (2010) -
Lap-Protector and Circular Stapler Are Useful in Cystogastrostomy for Large Pancreatic Pseudocyst with Severe Infection
por: Kadowaki, Yoshihiko, et al.
Publicado: (2010) -
Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention
por: Ohkoshi, Shogo, et al.
Publicado: (2010) -
Treatment with Corticosteroid for Pericardial Effusion in a Patient with Advanced Synchronous Esophageal and Gastric Cancers following Chemoradiotherapy
por: Osawa, Satoshi, et al.
Publicado: (2010) -
Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis
por: Mitsuka, Yuusuke, et al.
Publicado: (2010)